Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of methylphenidate on motor learning after stroke
2006-002554-29Phase 4Terminated
- Sponsor
- Hammel Neurocenter
- Start
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of methylphenidate in stroke (2 arms), sponsored by Hammel Neurocenter. Primary endpoints: Changes in Motor Evoked Potentials (MEP), Changes in Intracortical Inhibition (ICI) and 1 more. Started Jun 2006; status: terminated.
02
Drugs
methylphenidate
03
Conditions
stroke
Beyond the preview
Go deeper on 2006-002554-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002554-29.